Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

The First Transcatheter Mitral Valve Implantation Was Completed at Sheba Medical Center

First Transcatheter Mitral Valve Implantation
The new transcatheter mitral valve procedure offers a minimally invasive solution for mitral regurgitation

Mitral regurgitation is a common condition in which the heart’s mitral valve leaflets do not close tightly, usually resulting from infection or one of a few cardiovascular connective tissue diseases. When this happens, blood flows backward from the heart’s left ventricle into the left atrium. This forces the heart to work harder to push blood through the body, which can cause fatigue and shortness of breath.

Until recently, the only treatment available for mitral regurgitation was a conventional mitral valve replacement surgery, an invasive procedure with a long recovery period. After receiving a patient suffering from underlying conditions that pose an increased risk for conventional mitral valve replacement surgery, Sheba Medical Center, for the first time in Israel, has opted to perform a new breakthrough transcatheter mitral valve implantation.

The Tendyne Bioprosthetic Mitral Valve System is a novel minimally invasive procedure that offers select patients who suffer from symptomatic, significant mitral regurgitation a safe and effective valve replacement. The procedure involves a small incision in the chest between the ribs in order to gain catheter access to the heart apex.

The first transcatheter mitral valve implantation performed at Sheba was completed successfully, and the second successful implantation followed soon after.

“This innovative procedure allows us to offer patients, who until recently had no medical solution, a new hope with minimal risks,” said Prof. Israel Barabash, Director of the Catheterization Services at Sheba Medical Center.

Prof. Victor Guetta, Head of the Invasive Cardiology Unit, added: “For me, the essence of medicine is not settling for improving existing procedures, but developing new ways to treat patients with conditions that currently remain untreated.”

First Transcatheter Mitral Valve Implantation
News Mar 26.
West Bank and Gaza Medical Professionals Attend a Milestone Sheba Oncology Conference
Highlighting the latest in cancer care, with a particular focus on pediatrics, the Recent Advances in Cancer Care (REACT) 2023 event was attended by over…
Read More
Isenia’s Battle
Isenia’s Battle with Alveolar Sarcoma
At 17, Isenia, a native of Semey, Kazakhstan, noticed a lump on her leg the size of a small apple. Initially, Isenia and her family…
Read More
Colon and Rectal Cancer
News Mar 14.
Sheba Study Indicates Readily-Available Drugs May Prevent Metastasis in Colon and Rectal Cancer Patients
Favorable responses to the treatment were noted by Prof. Shamgar Ben-Eliyahu, a neuroscientist specializing in psychoneuroimmunology (PNI) at TAU’s Sagol School of Neuroscience and School…
Read More